Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Ablation Methods for Ventricular Tachycardia Ablation. Part 2
Author(s): Maria Niespialowska-Steuden , John Silberbauer , Jaffar Al-Sheikhli , et al Added: 1 week ago

Electrophysiology & Arrhythmia
Ablation Methods for Ventricular Tachycardia Ablation. Part 1
Author(s): Maria Niespialowska-Steuden , John Silberbauer , Jaffar Al-Sheikhli , et al Added: 1 week ago

Electrophysiology & Arrhythmia
Dynamic Voltage Mapping of Ventricular Tachycardia Substrate
Author(s): Mark T Mills , Peter Calvert , Justin Chiong , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Ventricular Tachycardia After Cardioversion
Author(s): Eiad Habib , Mahmoud Abdelnabi , Ramzi Ibrahim , et al Added: 5 months ago

Electrophysiology & Arrhythmia

Heart Failure
Functional Substrate Mapping
Author(s): Jaffar Al-Sheikhli , Patrick Tran , Rafaella Siang , et al Added: 1 year ago

Electrophysiology & Arrhythmia
HRS 25: FIH VCAS Trial
Author(s): Vivek Reddy Added: 1 year ago
HRS 25 - First-in-human data from the FIH VCAS trial suggests the FieldForce Ablation system can effectively create transmural ablation lesions in patients with scar-related ventricular tachycardia (VT), with an 80% freedom from VT and ventricular fibrillation rate at 6 months.We are joined by Dr Vivek Reddy (Mount Sinai Hospital, New York, US) to discuss the findings from the prospective, first… View more

Electrophysiology & Arrhythmia
HRS 2026: Six-Month Outcomes from the Sphere-9 VT Early Feasibility Study
Author(s): Pasquale Santangeli Added: 1 week ago
HRS Congress 2026 — In this Arrhythmia Academy expert interview, Brad Wilson, Director of Medical Device Partnerships at Radcliffe and Arrhythmia Academy, speaks with Dr. Pasquale Santangeli (Cleveland Clinic, Ohio, USA) about six-month outcomes from the Sphere-9 VT early feasibility study.They review the Affera Sphere-9 lattice tip catheter and mapping-ablation system, a dual-energy, large… View more

Electrophysiology & Arrhythmia
Off-Label PFA: VT and Emerging Indications
Author(s): Ioanna Koniari Added: 1 month ago
EHRA 2026 — Dr Ioanna Koniari (University Hospital of Patras, Rio-Patras, Greece) joins us for a forward-looking discussion on the expanding role of pulsed field ablation beyond its established indications, with a focus on ventricular tachycardia and the frontier applications that are beginning to redefine the boundaries of PFA in clinical practice.As operator experience with PFA deepens and… View more

Electrophysiology & Arrhythmia
VT Symposium 2026
Start date: Oct 10, 2026 End date: Oct 09, 2026
VT Symposium 2026 – Annual International Symposium on Ventricular Arrhythmias (VT)The VT Symposium 2026 is a premier international meeting dedicated to ventricular tachycardia, complex ventricular arrhythmias and the prevention of sudden cardiac death. Held in New York with a global real-time livestream, the symposium offers an advanced, case-rich learning environment for experienced… View more

Electrophysiology & Arrhythmia
VT Ablation in High-Risk Patients: Risk Discussion Framework
Author(s): Francesco Santoro Added: 1 month ago
EHRA Congress 2026 — Dr Francesco Santoro (University of Foggia, Foggia, IT) joins us to explore how electrophysiologists can approach risk assessment and decision-making when considering catheter ablation in high-risk ventricular tachycardia patients — a population where the potential benefits of ablation must be carefully weighed against procedural complexity and patient frailty.Interview… View more

Electrophysiology & Arrhythmia